Advisory: Alerts on Bio Vitos Pharma withdrawn
March 25 (Reuters) - Please ignore alerts on Bio Vitos Pharma receiving remark statement from Nasdaq Stockholm. The alerts were published in an error from an old press release. To see Bio Vitos press release from Tuesday, please click: nFWN3Q812J. STORY_NUMBER:FWN3Q81F9 STORY_DATE:25/03/2025 STORY_TIME:[03:35:57] (Reporting by Bartosz Dabrowski in Gdansk) ((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln